Migraine induced by vascular K ATP channel activation is independent of HCN channel activity: A randomised controlled trial with translational validation
Cephalalgia · 2026-04 · 46 (4)
DOI: 10.1177/03331024261431770 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cephalalgia, online erschienen am 03.04.2026. Verfasst von Zixuan Alice Zhuang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Danish Headache Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: KATP Channels, Cromakalim, Migraine Disorders, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Candys Foundation, Danmarks Grundforskningsfond, Lundbeck Foundation Scholarship.
Abstract (Originalsprache)
Objective
To investigate whether blockade of hyperpolarisation-activated cyclic nucleotide-gated (HCN) channels modifies migraine induced by activation of vascular ATP-sensitive potassium (K ATP ) channels.
Methods
We conducted a single-centre, randomised, double-blind, placebo-controlled, two-way crossover study in adults with migraine without aura. On two separate days, participants received intravenous levcromakalim followed immediately by either oral ivabradine or placebo in a balanced order. The primary endpoint was the 12-h incidence of levcromakalim-induced migraine. Secondary endpoints included the area under the curve (AUC) for headache intensity and haemodynamic responses. Parallel preclinical experiments were performed in a validated mouse model using von Frey-based tactile sensitivity to assess whether ivabradine, given as pretreatment or as rescue medication, alters levcromakalim-induced hypersensitivity.
Results
Twenty seven of 31 individuals completed the human study and provided data for the final analysis. Ivabradine did not modify the incidence of levcromakalim-induced migraine (22 of 27 after ivabradine and 22 of 27 after placebo; P > 0.99) or the AUC for headache intensity ( P = 0.11). Haemodynamic responses did not differ between study days. In mice, ivabradine at multiple doses neither prevented nor reversed tactile hypersensitivity induced by repeated levcromakalim administration.
Conclusions
HCN channel blockade does not influence migraine or nociceptive behaviour provoked by vascular K ATP channel activation. These convergent human and preclinical findings indicate that HCN channels are not essential for the downstream transformation of vascular K ATP channel activation into migraine pain and support a model in which migraine initiation arises from signalling at the vessel-to-neuron interface.
Trial registration
ClinicalTrials.gov; NCT04853797; Registered: 16-03-2021. Preclinical experiments were not preregistered beyond the animal ethical license (2017-15-0201-01358) from the Danish Animal Experiments Inspectorate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Danish Headache Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Neurology and Psychiatry, Difficult-to-Treat Headache Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Translational Research Centre, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Science and Environment, Roskilde University, Roskilde, Denmark.
- Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet-Glostrup, Copenhagen, Denmark.
ORCID-Profile: Zixuan Alice Zhuang, Janu Thuraiaiyah, Lili Kokoti, Rogelio Dominguez Moreno, Emil Gozalov, Zahra Hakimzadeh, Mohammad Al-Mahdi Al-Karagholi, Amalie Clement, David M Kristensen, Jawdat Abdulla, Sarah Louise Christensen, Messoud Ashina
Förderung
- Candys Foundation
- Danmarks Grundforskningsfond
- Lundbeck Foundation Scholarship
- Lundbeck Foundation Professor Grant
- Foreningen til støtte af forskning ved Dansk Hovedpine Center
- BRIDGE – Translational Excellence Programme, Faculty of Health and Medical Sciences, University of Copenhagen, supported by the Novo Nordisk Foundation
- Rigshospitalets Forskningspuljer
Zitieren
APA
Zhuang, Z. A., Thuraiaiyah, J., Kokoti, L., Moreno, R. D., Gozalov, E., Hakimzadeh, Z., Al-Karagholi, M. A., Clement, A., Kristensen, D. M., Abdulla, J., Christensen, S. L., & Ashina, M. (2026). Migraine induced by vascular K ATP channel activation is independent of HCN channel activity: A randomised controlled trial with translational validation. Cephalalgia, 46(4). https://doi.org/10.1177/03331024261431770
Vancouver
Zhuang ZA, Thuraiaiyah J, Kokoti L, Moreno RD, Gozalov E, Hakimzadeh Z, et al. Migraine induced by vascular K ATP channel activation is independent of HCN channel activity: A randomised controlled trial with translational validation. Cephalalgia. 2026;46(4). doi:10.1177/03331024261431770
BibTeX
@article{Zhuang2026,
author = {Zhuang, Zixuan Alice and Thuraiaiyah, Janu and Kokoti, Lili and Moreno, Rogelio Dominguez and Gozalov, Emil and Hakimzadeh, Zahra and Al-Karagholi, Mohammad Al-Mahdi and Clement, Amalie and Kristensen, David M and Abdulla, Jawdat and Christensen, Sarah Louise and Ashina, Messoud},
title = {Migraine induced by vascular K ATP channel activation is independent of HCN channel activity: A randomised controlled trial with translational validation},
journal = {Cephalalgia},
year = {2026},
volume = {46},
number = {4},
doi = {10.1177/03331024261431770}
}
EUVIMED